Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients

Digestive Diseases and Sciences

Volumn 52, Issue 2, 2007, Pages 347-352

  Papas, Konstantinos ^a   Kalbfleisch, John ^b   Mohon, Ricky ^b  

^a Yasoo HealthInc   (United States)

^b East Tennessee State University   (United States)

Author keywords

Bioavailability; Cholestasis; Cystic fibrosis; Malabsorption; Nutrition; Tocopherol; TPGS; Vitamin E; Vitamin E deficiency; Water soluble

Indexed keywords

ALPHA TOCOPHEROL; AQUA E; GAMMA TOCOPHEROL; TOCOPHEROL; UNCLASSIFIED DRUG; VITAMIN E FACTOR;

AREA UNDER THE CURVE; ARTICLE; BLOOD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; HUMAN; MALABSORPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; UNSPECIFIED SIDE EFFECT; VITAMIN SUPPLEMENTATION;

ADOLESCENT; ADULT; ALPHA-TOCOPHEROL; ANTIOXIDANTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHILD; CYSTIC FIBROSIS; DOSAGE FORMS; GAMMA-TOCOPHEROL; HUMANS; INTESTINAL ABSORPTION; LIPIDS; MALABSORPTION SYNDROMES; POLYETHYLENE GLYCOLS; SOLUBILITY; SOLVENTS; TOCOPHEROLS; VITAMIN E; WATER;

EID: 33846785479     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9489-2     Document Type: Article

References (36)

1. Feranchak AP (2004) Hepatobiliary complications of cystic fibrosis. Curr Gastroenterol Rep 6:231-239
2. Colombo C, Battezzati PM (1996) Hepatobiliary manifestations of cystic fibrosis. Eur J Gastroenterol Hepatol 8:748-754
3. Bargon J, Stein J, Dietrich CF, Muller U, Caspary WF, Wagner TO (1999) [Gastrointestinal complications of adult patients with cystic fibrosis]. Z Gastroenterol 37:739-749
4. Walters MP, Littlewood JM (1998) Faecal bile acid and dietary residue excretion in cystic fibrosis: age group variations. J Pediatr Gastroenterol Nutr 27:296-300
5. Strandvik B (2004) Fatty acidmetabolism in cystic fibrosis. N Engl J Med 350:605-607
6. O'Brien S, Mulcahy H, Fenlon H, O'Broin A, Casey M, Burke A, FitzGerald MX, Hegarty JE (1993) Intestinal bile acid malabsorption in cystic fibrosis. Gut 34:1137-1141
7. Kalivianakis M, Minich D (1999) Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr 69:127-134
8. Back E, Frindt C, Nohr D, Frank J, Ziebach R, Stern M, Ranke M, Biesalski HK (2004) Antioxidant deficiency in cystic fibrosis: when is the right time to take action? Am J Clin Nutr 80:374-384
9. Lancellotti L, D'Orazio C, Mastella G, Mazzi G, Lippi U (1996) Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation. Eur J Pediatr 155:281-285
10. Wood L, Fitzgerald DA, Gibson PG, Cooper DM, Collins CE, Garg ML (2001) Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr 20(2 Suppl):157-165
11. Homnick DN, Cox JH, DeLoof MJ, Ringer TV (1993) Carotenoid levels in normal children and in children with cystic fibrosis. J Pediatr 122(5 Pt 1):703-707
12. Sokol R, Papas AM (1998) Antioxidants and neurological diseases. In: Papas AM (ed) Antioxidant status, diet, nutrition and health. CRC Press, Boca Raton, pp 567-590
13. Kayden H, Traber MG (1993) Absorption, lipoprotein transport and regulation of plasma concentrations of vitamin E in humans. J Lipid Res 34:343-358
14. Brown R, Wyatt H, Price JF, Kelly FJ (1996) Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 9:334-339
15. Renner S, Rath R, Rust P, Lehr S, Frischer T, Elmadfa I, Eichler I (2001) Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis. Thorax 56:48-52.
16. Winklhofer-Roob BM, van't Hof MA, Shmerling DH (1996) Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations. Am J Clin Nutr 63:722-728.
17. Winklhofer-Roob B, Ziouzenkova O, Puhl H, Ellemunter H, Greiner P, Muller G, van't Hof MA, Esterbauer H, Shmerling DH (1995) Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation. Free Radic Biol Med 19:725-733
18. Wood L, Fitzgerald DA, Lee AK, Garg ML (2003) Improved antioxidant and fatty acid status of patients with cystic fibrosis after antioxidant supplementation is linked to improved lung function. Am J Clin Nutr 77:150-159
19. Wolf G (1997) gamma-Tocopherol: an efficient protector of lipids against nitric oxide-initiated peroxidative damage. Nutr Rev 55:376-378
20. Molina J, Jimenez-Jimenez FJ, Orti-Pareja M, Navarro J (1998) The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention. Drugs Aging 12:251-259
21. Feranchak A, Sontag MK, Wagener JS, Hammond KB, Accurso FJ, Sokol RJ (1999) Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr 135:601-610
22. Boyle MP, Noschese ML, Watts SL, Davis ME, Stenner SE, Lechtzin N (2005) Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. Am J Respir Crit Care Med 172:212-217
23. Soltani-Frisk S, Gronowitz E, Andersson H, Strandvik B (2001) Water-miscible tocopherol is not superior to fat-soluble preparation for vitamin E absorption in cystic fibrosis. Acta Paediatr 90:1112-1115
24. Dintaman J, Silverman JA (1999) Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 16:1550-1556
25. Argao E, Heubi JE, Hollis BW, Tsang RC (1992) d-Alpha-tocopheryl polyethylene glycol 1 000 succinate enhances the absorption of vitamin D in chronic cholestatic liver disease of infancy and childhood. Pediatr Res 31:146-150
26. Dimitrov NV, Meyer-Leece C, McMillan J, Gilliland D, Perloff M, Malone W (1996) Plasma alpha-tocopherol concentrations after supplementation with water- and fat-soluble vitamin E. Am J Clin Nutr 64:329-335
27. Jiang Q, Elson-Schwab I, Courtemanche C, Ames BN (2000) Gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci U S A 97:11494-11499
28. Jiang Q, Ames BN (2003) Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J 17:816-822
29. Himmelfarb J, Kane J, McMonagle E, Zaltas E, Bobzin S, Boddupalli S, Phinney S, Miller G (2003) Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease. Kidney Int 64:978-991
30. Helzlsouer KJ, Huang HY, Alberg AJ, Hoffman S, Burke A, Norkus EP, Morris JS, Comstock GW (2000) Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 92:2018-2023
31. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS, Aggarwal NT, Scherr PA (2005) Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr 81:508-514
32. Naito Y, Shimozawa M, Kuroda M, Nakabe N, Manabe H, Katada K, Kokura S, Ichikawa H, Yoshida N, Noguchi N, Yoshikawa T (2005) Tocotrienols reduce 25-hydroxycholesterol-induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis 180:19-25
33. Wada S, Satomi Y, Murakoshi M, Noguchi N, Yoshikawa T, Nishino H (2005) Tumor suppressive effects of tocotrienol in vivo and in vitro. Cancer Lett 229:181-191
34. Sen CK, Khanna S, Roy S, Packer L (2000) Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells. J Biol Chem 275:13049-13055
35. Handelman GJ, Epstein WL, Peerson J, Spiegelman D, Machlin LJ, Dratz EA (1994) Human adipose alpha-tocopherol and gamma-tocopherol kinetics during and after 1 y of alpha-tocopherol supplementation. Am J Clin Nutr 59:1025-1032
36. Traber MG, Kayden HJ (1989) Preferential incorporation of alpha-tocopherol vs gamma-tocopherol in human lipoproteins. Am J Clin Nutr 49:517-526